| Drug-metabolizing enzymes: role in drug resistance in cancer G Kaur, SK Gupta, P Singh, V Ali, V Kumar, M Verma Clinical and Translational Oncology 22, 1667-1680, 2020 | 85 | 2020 |
| Combating TKI resistance in CML by inhibiting the PI3K/Akt/mTOR pathway in combination with TKIs: A review P Singh, V Kumar, SK Gupta, G Kumari, M Verma Medical Oncology 38, 1-16, 2021 | 46 | 2021 |
| Transport and metabolism of tyrosine kinase inhibitors associated with chronic myeloid leukemia therapy: a review V Kumar, P Singh, SK Gupta, V Ali, M Verma Molecular and Cellular Biochemistry 477 (4), 1261-1279, 2022 | 28 | 2022 |
| Alterations in cellular metabolisms after Imatinib therapy: a review V Kumar, P Singh, SK Gupta, V Ali, Jyotirmayee, M Verma Medical Oncology 39 (7), 95, 2022 | 6 | 2022 |
| Developing therapeutic approaches for chronic myeloid leukemia: a review V Kumar, Jyotirmayee, M Verma Molecular and Cellular Biochemistry 478 (5), 1013-1029, 2023 | 4 | 2023 |
